| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| Other Sizes |
|
| ln Vitro |
A549 cells and H1299 cells trigger NK cell degranulation, which is enhanced by ingenol 3,20-dibenzoate (0–1000 nM; 4 hours) [2]. With an EC50 of 0.27 μg/mL (485 nM), ingenol 3,20-dibenzoate (0.001-10 μg/mL) dose-signally stimulates UT-7/EPO cell proliferation [3].
|
|---|---|
| ln Vivo |
Ingenol 3,20-dibenzoate (20 μg/mouse; i.p.; on days 3, 7, and 11) inhibited the cooling of 5-fluorouric route replacement in an in vivo simulation model [3 ].
|
| Animal Protocol |
Animal/Disease Models: Male C57BL/6 mice (8-12 weeks old) [3]
Doses: 20 μg/mouse Route of Administration: intraperitoneal (ip) injection; results on days 3, 7 and 11: IDB treatment alleviated on days 12 and 20 The severity of anemia caused by 5-FU. |
| References |
|
| Additional Infomation |
Ingenol 3,20-dibenzoate is a benzoate ester.
See also: Ingenol dibenzoate (annotation moved to). |
| Molecular Formula |
C34H36O7
|
|---|---|
| Molecular Weight |
556.66
|
| Exact Mass |
556.246
|
| CAS # |
59086-90-7
|
| PubChem CID |
442043
|
| Appearance |
White to off-white solid powder
|
| Density |
1.32 g/cm3
|
| Boiling Point |
697ºC at 760 mmHg
|
| Flash Point |
221.6ºC
|
| Index of Refraction |
1.639
|
| LogP |
4.544
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
7
|
| Rotatable Bond Count |
7
|
| Heavy Atom Count |
41
|
| Complexity |
1160
|
| Defined Atom Stereocenter Count |
8
|
| SMILES |
C[C@@H]1C[C@@H]2[C@@H](C2(C)C)[C@@H]3C=C([C@H]([C@]4([C@@]1(C3=O)C=C([C@@H]4OC(=O)C5=CC=CC=C5)C)O)O)COC(=O)C6=CC=CC=C6
|
| InChi Key |
GIMKEHNOTHXONN-NXBFFCPZSA-N
|
| InChi Code |
InChI=1S/C34H36O7/c1-19-17-33-20(2)15-25-26(32(25,3)4)24(28(33)36)16-23(18-40-30(37)21-11-7-5-8-12-21)27(35)34(33,39)29(19)41-31(38)22-13-9-6-10-14-22/h5-14,16-17,20,24-27,29,35,39H,15,18H2,1-4H3/t20-,24+,25-,26+,27-,29+,33+,34+/m1/s1
|
| Chemical Name |
[(1S,4S,5S,6R,9S,10R,12R,14R)-4-benzoyloxy-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxo-7-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl]methyl benzoate
|
| Synonyms |
IDB; Ingenol 3,20 dibenzoate; Ingenol 3,20-dibenzoate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~100 mg/mL (~179.65 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 5 mg/mL (8.98 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.7964 mL | 8.9821 mL | 17.9643 mL | |
| 5 mM | 0.3593 mL | 1.7964 mL | 3.5929 mL | |
| 10 mM | 0.1796 mL | 0.8982 mL | 1.7964 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
